Daily as of 3 Nov 16:00 ET
- Price
- below both $4.69 vs 50 $5.55 / 200 $5.38
- Projection
- 💀Death cross projected in 5 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 11 Aug 2026 · projected 25 bars out · tested 1 bar
NUVB | Nuvation BioNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history
$4.69
+$0.10 (+2.18%)
Nuvation Bio (NUVB) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Aug 2026, but the two have been closing on each other and a death cross is projected within 10 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $4.76 vs 50 $5.85 / 200 $3.20
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 3 Nov 2025 · projected 20 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $4.69 vs 50 $4.81 / 200 $5.83
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 8 Oct 2026 · projected 28 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 8 Oct 2026 | 💀Death | 4-hour | 28 bars out | Not tested |
| 11 Aug 2026 | 🟨Golden steep | daily | 25 bars out | 1 bar cross test |
| 24 Jun 2026 | 🟨Golden | 4-hour | 27 bars out | Not tested |
| 23 Apr 2026 | 💀Death moderate | daily | 22 bars out | 2 bar cross test |
| 13 Feb 2026 | 💀Death | 4-hour | 27 bars out | 6 bar cross test |
About NUVB
ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$26.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandmid